Abstract
Pharmacological activation of the large-conductance Ca2+-activated K+ channel (KCa1.1) in the cardiac inner mitochondrial membrane has been found to protect the heart against ischemia reperfusion injuries. However, there are concerns about the selectivity of the pharmacological tools used to modulate the channel. Here, we address this issue by synthesising a methylated analogue of the tool KCa1.1 channel activator NS11021. The compound (NS13558) is designed as a structurally closely related and biologically inactive analogue of NS11021. NS13558 did not elicit any significant opening of cloned human KCa1.1 channels, but maintained comparable biological activity towards other cardiac ion channels as compared to NS11021. In isolated perfused rat hearts subjected to ischemia–reperfusion, infarct size was reduced from 29% in control to 7% in NS11021 treated hearts. In comparison, the inactive derivate of NS11021, i.e., NS13558, did not confer any cardioprotection, demonstrated by an infarct size identical to control hearts. This suggests that NS11021 exerts its primary effect through KCa1.1 channels, which indicates an important role of these channels in protection against ischemia–reperfusion injuries. Furthermore, the study demonstrates a novel way of combining an activator of the KCa1.1 channel (NS11021) and its structurally closely related inactive analogue NS13558 to address the functional role of KCa1.1 channels, and we believe these novel tools may constitute a valuable addition to understanding the functional role of KCa1.1 channels under physiological and pathophysiological conditions.
Similar content being viewed by others
Abbreviations
- HEK-cells:
-
human embryonic kidney 293 cells
- DMSO:
-
dimethyl sulphoxide
- LVDP:
-
Left ventricular developed pressure
- LVeDP:
-
left ventricular end-diastolic pressure
- TTC:
-
2,3,5-triphenyltetrazolium chloride
- APD:
-
action potential duration at 90% repolarization
- UPLC:
-
ultra performance liquid chromatography
- MS:
-
mass spectrometry
- FT-IR:
-
Fourier transform infrared spectroscopy
- HPLC:
-
high-performance liquid chromatography
- ESI-HRMS:
-
electron spray ionisation high resolution mass spectra
- LC:
-
liquid chromatography
- M.p.:
-
melting point
References
Andreini F, Biagi G, Giorgi I, Livi O, Scartoni V (1989) Modification of the 1, 2, 3-triazole ring present in an effective in vitro inhibitor of the prostaglandin synthesis. Farmaco 44:831–841
Bentzen BH, Nardi A, Calloe K, Madsen LS, Olesen SP, Grunnet M (2007) The small molecule NS11021 is a potent and specific activator of Ca2+-activated big-conductance K+ channels. Mol Pharmacol 72:1033–1044
Bentzen BH, Osadchii O, Jespersen T, Hansen RS, Olesen SP, Grunnet M (2008) Activation of big conductance Ca(2+)-activated K(+) channels (BK) protects the heart against ischemia–reperfusion injury. Pflugers Arch
Cancherini DV, Queliconi BB, Kowaltowski AJ (2007) Pharmacological and physiological stimuli do not promote Ca(2+)-sensitive K+ channel activity in isolated heart mitochondria. Cardiovasc Res 73:720–728
Cao CM, Xia Q, Gao Q, Chen M, Wong TM (2005) Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning. J Pharmacol Exp Ther 312:644–650
De Boer TJ, Backer HJ (1963) Diazomethane. Org Synth 36:16–19
Debska G, Kicinska A, Dobrucki J, Dworakowska B, Nurowska E, Skalska J, Dolowy K, Szewczyk A (2003) Large-conductance K+ channel openers NS1619 and NS004 as inhibitors of mitochondrial function in glioma cells. Biochem Pharmacol 65:1827–1834
Douglas RM, Lai JC, Bian S, Cummins L, Moczydlowski E, Haddad GG (2006) The calcium-sensitive large-conductance potassium channel (BK/MAXI K) is present in the inner mitochondrial membrane of rat brain. Neuroscience 139:1249–1261
Edwards G, Niederste-Hollenberg A, Schneider J, Noack T, Weston AH (1994) Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle. Br J Pharmacol 113:1538–1547
Grunnet M, Jensen BS, Olesen SP, Klaerke DA (2001) Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels. Pflugers Arch 441:544–550
Halestrap AP, Clarke SJ, Khaliulin I (2007) The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 1767:1007–1031
Hansen RS, Diness TG, Christ T, Demnitz J, Ravens U, Olesen SP, Grunnet M (2006) Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol 69:266–277
Heinen A, Camara AK, Aldakkak M, Rhodes SS, Riess ML, Stowe DF (2007) Mitochondrial Ca2+-induced K+ influx increases respiration and enhances ROS production while maintaining membrane potential. Am J Physiol Cell Physiol 292:C148–C156
Holland GF, Pereira JN (1967) Heterocyclic tetrazoles, a new class of lipolysis inhibitors. J Med Chem 10:149–154
Holland M, Langton PD, Standen NB, Boyle JP (1996) Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle. Br J Pharmacol 117:119–129
Jespersen T, Grunnet M, Angelo K, Klaerke DA, Olesen SP (2002) Dual-function vector for protein expression in both mammalian cells and Xenopus laevis oocytes. Biotechniques 32:536–540
Longland CL, Dyer JL, Michelangeli F (2000) The mycotoxin paxilline inhibits the cerebellar inositol 1,4,5-trisphosphate receptor. Eur J Pharmacol 408:219–225
Nardi A, Olesen S-P (2008) Curr Med Chem 15:1126–1146
Nardi A, Demnitz D, Grunnet M, Christophersen P, Jones DS, Nielsen EO, Stroebaek D, Madsen LS (2008a) Preparation of novel biphenyl thiourea derivatives useful as potassium channel modulators. PCT Int Appl WO/2008/074756
Nardi A, Christensen JK, Christophersen P, Jones DS, Nielsen EO, Stroebaek D, Madsen LS (2008b) Preparation of novel aromatic heterocyclic carboxylic acid amide derivatives as potassium channel modulators. PCT Int Appl WO/2008/138917
Nardi A, Demnitz D, Grunnet M, Christophersen P, Jones DS, Nielsen EO, Stroebaek D, Madsen LS (2008c) Preparation of novel benzamidine derivatives as potassium channel modulators. PCT Int Appl WO/2008/135591
Nardi A, Demnitz D, Grunnet M, Christophersen P, Jones DS, Nielsen EO, Stroebaek D, Madsen LS (2008d) Preparation of β-keto-amide derivatives useful as ion channel modulators. PCT Int Appl WO/2008/135448
Nardi A, Grunnet M, Christophersen P, Demnitz J, Jones DS, Nielsen EO, Stroebaek D, Madsen LS (2008e) Preparation of acetamide derivatives as potassium channel modulators. PCT Int Appl WO/2008/135447
Nardi A, Grunnet M, Christophersen P, Demnitz J, Jones DS, Nielsen EO, Stroebaek D, Madsen LS (2008f) Preparation of diaryltriazole derivatives for use as potassium channel modulators. PCT Int Appl WO/2008/087178
Nardi A, Demnitz D, Grunnet M, Christophersen P, Jones DS, Nielsen EO, Stroebaek D, Madsen LS (2008g) Preparation of novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators. PCT Int Appl WO/2008/087177
Nardi A, Grunnet M, Demnitz J, Jensen TD, Christophersen P, Jones DS, Nielsen EO, Stroebaek D, Madsen LS (2008h) Preparation of novel cinnamic amide derivatives useful as ion channel modulators. PCT Int Appl WO/2008/074755
Nardi A, Christensen JK, Jones DS (2009) Preparation of novel pyrazole derivatives useful as potassium channel modulators. PCT Int Appl WO/2009/003921
O’Rourke B (2007) Mitochondrial ion channels. Annu Rev Physiol 69:19–49
Ohya S, Kuwata Y, Sakamoto K, Muraki K, Imaizumi Y (2005) Cardioprotective effects of estradiol include the activation of large-conductance Ca(2+)-activated K(+) channels in cardiac mitochondria. Am J Physiol Heart Circ Physiol 289:1635–1642
Olesen SP, Munch E, Moldt P, Drejer J (1994) Selective activation of Ca(2+)-dependent K+ channels by novel benzimidazolone. Eur J Pharmacol 251:53–59
Park WS, Kang SH, Son YK, Kim N, Ko JH, Kim HK, Ko EA, Kim CD, Han J (2007) The mitochondrial Ca2+-activated K+ channel activator, NS 1619 inhibits l-type Ca2+ channels in rat ventricular myocytes. Biochem Biophys Res Commun 362:31–36
Sakamoto K, Nonomura T, Ohya S, Muraki K, Ohwada T, Imaizumi Y (2006) Molecular mechanisms for large conductance Ca2+-activated K+ channel activation by a novel opener, 12,14-dichlorodehydroabietic acid. J Pharmacol Exp Ther 316:144–153
Sakamoto K, Ohya S, Muraki K, Imaizumi Y (2008) A novel opener of large-conductance Ca2+-activated K+ (BK) channel reduces ischemic injury in rat cardiac myocytes by activating mitochondrial K(Ca) channel. J Pharmacol Sci 108:135–139
Saleh SN, Angermann JE, Sones WR, Leblanc N, Greenwood IA (2007) Stimulation of Ca2+-gated Cl-currents by the calcium-dependent K+ channel modulators NS1619 [1, 3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2 H-benzimidazol-2-one] and isopimaric acid. J Pharmacol Exp Ther 321:1075–1084
Siemen D, Loupatatzis C, Borecky J, Gulbins E, Lang F (1999) Ca2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line. Biochem Biophys Res Commun 257:549–554
Wang X, Yin C, Xi L, Kukreja RC (2004) Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice. Am J Physiol Heart Circ Physiol 287:H2070–H2077
Xu W, Liu Y, Wang S, McDonald T, Van Eyk JE, Sidor A, O’Rourke B (2002) Cytoprotective role of Ca2+-activated K+ channels in the cardiac inner mitochondrial membrane. Science 298:1029–1033
Acknowledgements
We thank Camilla Irlind for excellent technical assistance. This study was supported by the Novo Nordisk Foundation, the Aase and Ejnar Danielsen Foundation, the Danish National Research Foundation Centre for Cardiac Arrhythmia, and the Danish Medical Research Council.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bentzen, B.H., Andersen, R.W., Olesen, SP. et al. Synthesis and characterisation of NS13558: a new important tool for addressing KCa1.1 channel function ex vivo. Naunyn-Schmied Arch Pharmacol 381, 271–283 (2010). https://doi.org/10.1007/s00210-009-0456-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-009-0456-2